UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 688

Sortiert nach

B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.1011-1016

2008

Volltextzugriff (PDF)

A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older

Vaccine, 2024-07

2024

Volltextzugriff (PDF)

B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels

Arthritis research & therapy, 2006-01, Vol.8 (1), p.R6-R6

2006

Volltextzugriff (PDF)

B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

Rheumatology (Oxford, England), 2007-01, Vol.46 (1), p.37-43

2007

Volltextzugriff (PDF)

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation

Mucosal immunology, 2011-03, Vol.4 (2), p.172-185

2011

Volltextzugriff (PDF)

BAFF and BAFF‐R Levels Are Associated With Risk of Long‐Term Kidney Graft Dysfunction and Development of Donor‐Specific Antibodies

American journal of transplantation, 2012-10, Vol.12 (10), p.2754-2762

2012

Volltextzugriff (PDF)

Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development

Science (American Association for the Advancement of Science), 1995-11, Vol.270 (5237), p.797-800

1995

Volltextzugriff (PDF)

Different Interleukin 2 Receptor β -Chain Tyrosines Couple to at Least Two Signaling Pathways and Synergistically Mediate Interleukin 2-Induced Proliferation

Proceedings of the National Academy of Sciences - PNAS, 1996-03, Vol.93 (5), p.2077-2082

1996

Volltextzugriff (PDF)

Synthesis and release of B-lymphocyte stimulator from myeloid cells

Blood, 2001-01, Vol.97 (1), p.198-204

2001

Volltextzugriff (PDF)

Recruitment of SH2-Containing Protein Tyrosine Phosphatase SHP-1 to the Interleukin 2 Receptor; Loss of SHP-1 Expression in Human T-Lymphotropic Virus Type I-Transformed T Cells

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (7), p.3845-3850

1998

Volltextzugriff (PDF)

BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases

The Journal of immunology (1950), 2002-10, Vol.169 (8), p.4314-4321

2002

Volltextzugriff (PDF)

A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies

Blood cancer journal (New York), 2015-05, Vol.5 (5), p.e316-e316

2015

Volltextzugriff (PDF)

Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain

The EMBO journal, 1999-03, Vol.18 (6), p.1549-1558

1999

Volltextzugriff (PDF)

B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor α antagonists: differential effects between good and poor clinical responders

Annals of the rheumatic diseases, 2008-08, Vol.67 (8), p.1132-1138

2008

Volltextzugriff (PDF)

Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.535-547

2005

Volltextzugriff (PDF)

CIS Associates with the Interleukin-2 Receptor β Chain and Inhibits Interleukin-2-dependent Signaling

The Journal of biological chemistry, 1999-10, Vol.274 (42), p.30266-30272

1999

Volltextzugriff (PDF)

The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15

Immunity (Cambridge, Mass.), 1995-04, Vol.2 (4), p.331-339

1995

Volltextzugriff (PDF)

Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS

The Journal of biological chemistry, 2000-11, Vol.275 (45), p.35478-35485

2000

Volltextzugriff (PDF)

Constitutively Activated Jak-STAT Pathway in T Cells Transformed with HTLV-I

Science (American Association for the Advancement of Science), 1995-07, Vol.269 (5220), p.79-81

1995

Volltextzugriff (PDF)

Proliferation of Adult T Cell Leukemia/Lymphoma Cells is Associated with the Constitutive Activation of JAK/STAT Proteins

Proceedings of the National Academy of Sciences - PNAS, 1997-12, Vol.94 (25), p.13897-13902

1997

Volltextzugriff (PDF)

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P402-P402, Article P402

2009

Volltextzugriff (PDF)

TIP, a T-cell factor identified using high-throughput screening increases survival in a graft- versus -host disease model

Nature biotechnology, 2003-03, Vol.21 (3), p.302-307

2003

Volltextzugriff (PDF)

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

Blood, 2001-09, Vol.98 (6), p.1935-1941

2001

Volltextzugriff (PDF)

TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell Costimulator

Immunity (Cambridge, Mass.), 2002-03, Vol.16 (3), p.479-492

2002

Volltextzugriff (PDF)

Functional Cooperation of the Interleukin-2 Receptor β Chain and Jak1 in Phosphatidylinositol 3-Kinase Recruitment and Phosphorylation

Molecular and Cellular Biology, 1998-11, Vol.18 (11), p.6416-6422

1998

Volltextzugriff (PDF)

1 – 25 von 688

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(552)
Mit Volltextzugriff
(584)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(347)
Humans
(260)
Life Sciences & Biomedicine
(256)
Female
(129)
Male
(124)
Adult
(87)
Physical Sciences
(82)
Biological And Medical Sciences
(80)
Middle Aged
(66)
Chemistry
(63)
Animals
(62)
Medical Sciences
(61)
Technology
(61)
Aged
(58)
Materials Science
(57)
Exact Sciences And Technology
(53)
Social Sciences
(53)
Materials Science, Multidisciplinary
(51)
Physics
(49)
Immunology
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older

B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels

B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation

BAFF and BAFF‐R Levels Are Associated With Risk of Long‐Term Kidney Graft Dysfunction and Development of Donor‐Specific Antibodies

Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development

Different Interleukin 2 Receptor β -Chain Tyrosines Couple to at Least Two Signaling Pathways and Synergistically Mediate Interleukin 2-Induced Proliferation

Synthesis and release of B-lymphocyte stimulator from myeloid cells

Recruitment of SH2-Containing Protein Tyrosine Phosphatase SHP-1 to the Interleukin 2 Receptor; Loss of SHP-1 Expression in Human T-Lymphotropic Virus Type I-Transformed T Cells

BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases

A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies

Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain

B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor α antagonists: differential effects between good and poor clinical responders

Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice

CIS Associates with the Interleukin-2 Receptor β Chain and Inhibits Interleukin-2-dependent Signaling

The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15

Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS

Constitutively Activated Jak-STAT Pathway in T Cells Transformed with HTLV-I

Proliferation of Adult T Cell Leukemia/Lymphoma Cells is Associated with the Constitutive Activation of JAK/STAT Proteins

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

TIP, a T-cell factor identified using high-throughput screening increases survival in a graft- versus -host disease model

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell Costimulator

Functional Cooperation of the Interleukin-2 Receptor β Chain and Jak1 in Phosphatidylinositol 3-Kinase Recruitment and Phosphorylation

Suchergebnisse filtern